Skip to main content
Journal of Clinical Oncology logoLink to Journal of Clinical Oncology
. 2020 Feb 7;38(6):656. doi: 10.1200/JCO.20.00023

ERRATA

PMCID: PMC7030888  PMID: 32065858

The July 1, 2018, article by Dowsett et al entitled “Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5” (J Clin Oncol 10.1200/JCO.2017.76.4258) was published with errors.

Figure 3 has been replaced. The authors incorrectly used the baseline risk from the BIG1-98 population. The errors do not affect their interpretation of the validation in the BIG1-98 population or the final CTS5 algorithm. The corrected version uses the baseline risk from the ATAC population.

The Figure 3 legend read as: Observed versus expected number of events and χ2 values in the BIG (Breast International Group) 1-98 trial according to deciles of Clinical Treatment Score post–5 years (ATAC [Arimidex, Tamoxifen, Alone or Combination]) for (A) node-negative and (B) node-positive patients. None of the χ2 were statistically significant.

It should have read as: Observed versus expected numbers of events and χ2 values in the BIG (Breast International Group) 1-98 trial according to deciles of Clinical Treatment Score post5 years (ATAC [Arimidex, Tamoxifen, Alone or Combination]) for (A) node-negative and (B) node-positive patients.

This has been corrected as of January 15, 2020. The authors apologize for the errors.


Articles from Journal of Clinical Oncology are provided here courtesy of American Society of Clinical Oncology

RESOURCES